Lifecode is a specialized CLIA and CAP certified clinical laboratory focused on the genetic basis of human disease. With an initial focus on oncology, we are committed to improving the lives of patients through molecular information that is concise, accurate and actionable. The long-term vision of Lifecode is to revolutionize the world of genomic medicine: better care through better code.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/23/15 | $20,500,000 | Series A |
Mayo Clinic Mayo Clinic Ventures | undisclosed |
